Clinical Trial

The Effect of Cardiac Rehabilitation on Oxidative DNA Damage and Inflammation in Patients With Coronary Artery Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 2, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study was to determine the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), an indicator of oxidative stress, and to demonstrate oxidative DNA damage in cardiac rehabilitation treatment in patients with coronary artery disease. Additionally, proinflammatory cytokines TNFα, IL-1β, and IL-6 levels were measured to evaluate the significance of cardiac rehabilitation treatment in patients with coronary artery disease and to assess the correlation between cytokine levels and 8-OHdG levels.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-05; most recent amendment 2025-04-29.
Trial Details
NCT Number NCT06867926
Lead Sponsor TC Erciyes University
Conditions Coronary Arterial Disease (CAD)
Enrollment 70 participants
Start Date 2025-05-15
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-02